We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$453M
AUM Growth
+$57.9M
Cap. Flow
+$54.8M
Cap. Flow %
12.09%
Top 10 Hldgs %
36.96%
Holding
92
New
18
Increased
38
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$17.1M
2
HCA icon
HCA Healthcare
HCA
+$12.4M
3
CVS icon
CVS Health
CVS
+$12.3M
4
DHR icon
Danaher
DHR
+$4.2M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$3.94M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$7.39M
2
DXCM icon
DexCom
DXCM
+$7.21M
3
PODD icon
Insulet
PODD
+$5.03M
4
RCUS icon
Arcus Biosciences
RCUS
+$4.64M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$4.58M

Sector Composition

Rank Sector Weight
1 Healthcare 95.63%
2 Industrials 1.69%
3 Technology 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$39.3B
$20.6M 4.55%
73,112
+3,243
+5% +$842K
UTHR icon
2
United Therapeutics
UTHR
$23.1B
$19.5M 4.3%
90,198
-4,126
-4% -$810K
DHR icon
3
Danaher
DHR
$144B
$19.4M 4.27%
66,379
+15,254
+30% +$4.2M
UNH icon
4
UnitedHealth
UNH
$370B
$19M 4.19%
+37,823
New +$17.1M
DXCM icon
5
DexCom
DXCM
$32B
$17.7M 3.9%
131,624
-50,208
-28% -$7.21M
AVTR icon
6
Avantor
AVTR
$9.19B
$17.2M 3.79%
407,575
-32,425
-7% -$1.28M
ACRS icon
7
Aclaris Therapeutics
ACRS
$869M
$14.9M 3.29%
1,025,522
-280,938
-22% -$4.26M
CVS icon
8
CVS Health
CVS
$122B
$13.8M 3.04%
+133,334
New +$12.3M
HCA icon
9
HCA Healthcare
HCA
$89.5B
$13M 2.87%
+50,661
New +$12.4M
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
$12.5M 2.76%
80,795
+8,119
+11% +$1.36M
NTRA icon
11
Natera
NTRA
$46.4B
$11.6M 2.57%
124,550
+34,503
+38% +$3.58M
XENE icon
12
Xenon Pharmaceuticals
XENE
$6.12B
$11.3M 2.49%
360,502
+49,295
+16% +$1.47M
XBI icon
13
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$11.2M 2.47%
+100,000
New +$12.1M
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.9M 2.4%
100,747
+20,980
+26% +$2.29M
CDXS icon
15
Codexis
CDXS
$158M
$10.6M 2.35%
340,152
+54,085
+19% +$1.78M
COO icon
16
Cooper Companies
COO
$14.5B
$9.94M 2.19%
94,860
-1,492
-2% -$152K
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$29.3B
$9.78M 2.16%
57,682
-17,285
-23% -$3.21M
CRL icon
18
Charles River Laboratories
CRL
$12.8B
$9.76M 2.15%
25,901
+901
+4% +$350K
IMUX icon
19
Immunic
IMUX
$195M
$9.32M 2.06%
97,418
+5,009
+5% +$451K
CDMO
20
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$8.46M 1.87%
290,000
-160,000
-36% -$4.58M
CTLT
21
DELISTED
CATALENT, INC.
CTLT
$7.8M 1.72%
60,939
+21,200
+53% +$2.72M
APEN
22
DELISTED
Apollo Endosurgery, Inc.
APEN
$7.74M 1.71%
918,485
+87,271
+10% +$762K
RCM
23
DELISTED
R1 RCM Inc. Common Stock
RCM
$7.66M 1.69%
300,395
+155,395
+107% +$3.73M
IRTC icon
24
iRhythm Holdings
IRTC
$4.2B
$7.29M 1.61%
61,980
+29,480
+91% +$2.7M
IDXX icon
25
Idexx Laboratories
IDXX
$46.2B
$7.22M 1.59%
10,970
+3,303
+43% +$2.07M
1
2 3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Parkman Healthcare Partners held 92 positions worth $453M, up 15% from $395M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners deployed $54.8M of net new capital in Q4 2021, opening 18 new positions and adding to 38 existing holdings. Its largest new stake was UnitedHealth: 37,823 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 98% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was DexCom, an estimated $7.21M trimmed.

  • Parkman Healthcare Partners's largest Q4 2021 buy was UnitedHealth: 37,823 shares worth $19M.
  • Parkman Healthcare Partners added most to Danaher in Q4 2021, an estimated $4.2M increase.
  • Parkman Healthcare Partners's biggest Q4 2021 reduction was DexCom, cutting an estimated $7.21M.
  • Parkman Healthcare Partners fully exited Humana in Q4 2021, selling an estimated $7.39M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $453M portfolio in Q4 2021.
  • Parkman Healthcare Partners opened 18 new positions and closed 8 in Q4 2021.
  • Parkman Healthcare Partners's portfolio value rose 15% quarter-over-quarter to $453M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2021, filed 11 Feb 2022.